Reference
FDA. Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for 'Off-Label' Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems. Internet Document : 24 Apr 2020. Available from: URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-reiterates-importance-close-patient-supervision-label-use
Rights and permissions
About this article
Cite this article
Antimalarial use in COVID-19 patients requires close monitoring. Reactions Weekly 1802, 1 (2020). https://doi.org/10.1007/s40278-020-77919-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-77919-y